Corticotropin-releasing hormone (CRH) and pro-opiomelanocortin (POMC) axis activation leads to the production of hormones, such as adrenocorticotrophic hormone (ACTH) and the α-melanocyte stimulating hormone (α-MSH). Data regarding the role of these hormones in systemic lupus erythematosus (SLE) are scarce. In the present study we aim to evaluate the participation of this axis in the cutaneous involvement of SLE.
Methods
Seventeen SLE patients were clinically evaluated, and biopsies from affected and unaffected skin of these patients were compared with 17 healthy control individuals. Immunohistochemical analyses for CRH, ACTH, α-MSH, and MC-1R were performed, and the serum levels of α-MSH, IL-1, IL-1ra, IL-6, IL-10, IL-12p70, IL-17, TNF-α, and IFN-γ were measured.
Results
The affected skin of the SLE patients exhibited higher CRH expression in the deep dermis compared to the skin of the controls (p = 0.024), whereas the tissue expression of ACTH, cortisol, α-MSH and its receptor MC-1R were comparable in SLE patients and controls. Higher serum levels of IFN-γ (p = 0.041), TNF-α (p = 0.001) and IL-6 (p = 0.049) were observed in SLE patients compared with controls, while α-MSH levels were similar in both groups.
Conclusion
The novel finding of elevated CRH expression solely in the affected skin deep dermis supports the notion of a cutaneous local dysfunction of the CRH-POMC axis in the pathogenesis of cutaneous SLE lesions.
SlominskiAWortsmanJTuckeyRCPausR. Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol2007; 265-266: 143–149.
2.
ItoiKSeasholtzAFWatsonSJ. Cellular and extracellular regulatory mechanisms of hypothalamic corticotropin-releasing hormone neurons. Endocr J1998; 45: 13–33.
3.
SlominskiAWortsmanJLugerTPausRSolomonS. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev2000; 80: 979–1020.
4.
SlominskiAWortsmanJPisarchikA. Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J2001; 15: 1678–1693.
5.
SlominskiATZmijewskiMAZbytekBTobinDJTheoharidesTCRivierJ. Key role of CRF in the skin stress response system. Endocr Rev2013; 34: 827–884.
6.
Slominski A, Zbytek B, Nikolakis G, et al. Steroidogenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol. 2013; 137: 107–123.
7.
ZbytekBMysliwskiASlominskiAWortsmanJWeiETMysliwskaJ. Corticotropin-releasing hormone affects cytokine production in human HaCaT keratinocytes. Life Sci2002; 70: 1013–1021.
8.
GancevicieneRBöhmMFimmelSZouboulisCC. The role of neuropeptides in the multifactorial pathogenesis of acne vulgaris. Dermatoendocrinol2009; 1: 170–176.
9.
KimJEChoDHKimHS. Expression of the corticotropin-releasing hormone-proopiomelanocortin axis in the various clinical types of psoriasis. Exp Dermatol2007; 16: 104–109.
10.
CataniaAAiraghiLColomboGLiptonJM. Alpha-melanocyte-stimulating hormone in normal human physiology and disease states. Trends Endocrinol Metab2000; 11: 304–308.
11.
CannonJGTatroJBReichlinSDinarelloCA. Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J Immunol1986; 137: 2232–2236.
12.
HiltzMECataniaALiptonJM. Alpha-MSH peptides inhibit acute inflammation induced in mice by rIL-1 beta, rIL-6, rTNF-alpha and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8. Cytokine1992; 4: 320–328.
13.
LugerTAScholzenTGrabbeS. The role of alpha-melanocyte-stimulating hormone in cutaneous biology. J Investig Dermatol Symp Proc1997; 2: 87–93.
14.
SlominskiAPausRWortsmanJ. On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol1993; 93: C1–C6.
15.
ThodyAJ. alpha-MSH and the regulation of melanocyte function. Ann N Y Acad Sci1999; 885: 217–229.
16.
ConeRDLuDKoppulaS. The melanocortin receptors: Agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Horm Res1996; 51: 287–317. discussion 318.
17.
ThodyAJGrahamA. Does alpha-MSH have a role in regulating skin pigmentation in humans?Pigment Cell Res1998; 11: 265–274.
18.
HasanTNybergFStephanssonE. Photosensitivity in lupus erythematosus, UV photoprovocation results compared with history of photosensitivity and clinical findings. Br J Dermatol1997; 136: 699–705.
19.
WenzelJZahnSTütingT. Pathogenesis of cutaneous lupus erythematosus: Common and different features in distinct subsets. Lupus2010; 19: 1020–1028.
20.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725.
21.
HawkerGGabrielSBombardierCGoldsmithCCaronDGladmanD. A reliability study of SLEDAI: A disease activity index for systemic lupus erythematosus. J Rheumatol1993; 20: 657–660.
22.
ClarkDThodyAJShusterSBowersH. Immunoreactive alpha-MSH in human plasma in pregnancy. Nature1978; 273: 163–164.
23.
CataniaAAiraghiLGarofaloLCutuliMLiptonJM. The neuropeptide alpha-MSH in HIV infection and other disorders in humans. Ann N Y Acad Sci1998; 840: 848–856.
24.
KatsukiASumidaYMurashimaS. Elevated plasma levels of alpha-melanocyte stimulating hormone (alpha-MSH) are correlated with insulin resistance in obese men. Int J Obes Relat Metab Disord2000; 24: 1260–1264.
25.
ToddDJKnowltonNAmatoM. Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor. Arthritis Rheum2011; 63: 894–903.
26.
EsparzaRHSwaakTAardenLSmeenkR. Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal. J Rheumatol1985; 12: 1109–1117.
27.
ElkonKBCulhaneL. Partial immunochemical characterization of the Ro and La proteins using antibodies from patients with the sicca syndrome and lupus erythematosus. J Immunol1984; 132: 2350–2356.
28.
KurataNTanEM. Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis Rheum1976; 19: 574–580.
29.
MooreGEHoenigM. Duration of pituitary and adrenocortical suppression after long-term administration of anti-inflammatory doses of prednisone in dogs. Am J Vet Res1992; 53: 716–720.
KontosAPJirsariMJacobsenGFivensonDP. Immunoglobulin M predominance in cutaneous lupus erythematosus. J Cutan Pathol2005; 32: 352–355.
32.
MikitaNIkedaTIshiguroMFurukawaF. Recent advances in cytokines in cutaneous and systemic lupus erythematosus. J Dermatol2011; 38: 839–849.
33.
MaczynskaIMilloBRatajczak-StefańskaV. Proinflammatory cytokine (IL-1beta, IL-6, IL-12, IL-18 and TNF-alpha) levels in sera of patients with subacute cutaneous lupus erythematosus (SCLE). Immunol Lett2006; 102: 79–82.
34.
GröndalGGunnarssonIRönnelidJRogbergSKlareskogLLundbergI. Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol2000; 18: 565–570.
35.
ChunHYChungJWKimHA. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol2007; 27: 461–466.
36.
YoshimasuTNishideTSeoN. Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: A novel model for drug-induced cutaneous lupus erythematosus. Clin Exp Immunol2004; 136: 245–254.
37.
BraunsteinIKleinROkawaJWerthVP. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score. Br J Dermatol2012; 166: 971–975.
38.
KimJEChoBKChoDHParkHJ. Expression of hypothalamic-pituitary-adrenal axis in common skin diseases: Evidence of its association with stress-related disease activity. Acta Derm Venereol2013; 93: 387–393.
SatoHNagashimaYChrousosGPIchihashiMFunasakY. The expression of corticotropin-releasing hormone in melanoma. Pigment Cell Res2002; 15: 98–103.
41.
VermiWLonardiSMorassiM. Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage. Immunobiology2009; 214: 877–886.
42.
Auriemma M, Brzoska T, Klenner L, et al. α-MSH-stimulated tolerogenic dendritic cells induce functional regulatory T cells and ameliorate ongoing skin inflammation. J Invest Dermatol 2012; 132: 1814–1824.
43.
BöhmMLugerTA. Alpha-melanocyte-stimulating hormone. Its current significance for dermatology [article in German]. Hautarzt2004; 55: 436–445.
44.
SlominskiAPawelekJ. Animals under the sun: Effects of ultraviolet radiation on mammalian skin. Clin Dermatol1998; 16: 503–515.
45.
MaidanaPBrunoODMeschV. A critical analysis of cortisol measurements: An update [article in Spanish]. Medicina (B Aires)2013; 73: 579–584.
46.
TsangAHBarclayJLOsterH. Interactions between endocrine and circadian systems. J Mol Endocrinol2014; 52: R1–R16.
47.
SlominskiAGomez-SanchezCEFoeckingMFWortsmanJ. Metabolism of progesterone to DOC, corticosterone and 18OHDOC in cultured human melanoma cells. FEBS Lett1999; 455: 364–366.
48.
SlominskiAGomez-SanchezCEFoeckingMFWortsmanJ. Active steroidogenesis in the normal rat skin. Biochim Biophys Acta2000; 1474: 1–4.
49.
RogoffDGomez-SanchezCEFoeckingMFWortsmanJSlominskiA. Steroidogenesis in the human skin: 21-hydroxylation in cultured keratinocytes. J Steroid Biochem Mol Biol2001; 78: 77–81.
50.
SlominskiATZmijewskiMASkobowiatCZbytekBSlominskiRMSteketeeJD. Sensing the environment: Regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol2012; 212. v, vii, 1--115.
51.
TakeiKDendaSKumamotoJDendaM. Low environmental humidity induces synthesis and release of cortisol in an epidermal organotypic culture system. Exp Dermatol2013; 22: 662–664.
52.
Gądek-MichalskaATadeuszJRachawalskaPSpyrkaJBugajskiJ. Effect of prior stress on interleukin-1beta and HPA axis responses to acute stress. Pharmacol Reports2011; 63: 1393–1403.
53.
ZhuGJanjetovicZSlominskiA. On the role of environmental humidity on cortisol production by epidermal keratinocytes. Exp Dermatol2014; 23: 15–17.
